This inventor holds 6 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: The Ohio State University. Active years: 1998-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2016
Title: The Innovative Contributions of Pravin T Kaumaya
Introduction
Pravin T Kaumaya is a notable inventor based in Westerville, OH (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines and therapeutic compositions targeting malignancies associated with the HER-2 protein. With a total of 6 patents to his name, his work continues to influence advancements in medical science.
Latest Patents
Kaumaya's latest patents include innovative compositions and methods that may stimulate the immune system. One of his notable patents involves chimeric peptides comprising HER-2 B-cell epitopes and T-cell helper epitopes. These compositions are designed for treating malignancies associated with the overexpression of the HER-2 protein. Such advancements hold promise for improving therapeutic strategies in cancer treatment.
Career Highlights
Throughout his career, Pravin T Kaumaya has been associated with esteemed institutions such as The Ohio State University and the Ohio State Innovation Foundation. His work at these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Kaumaya has worked alongside notable colleagues, including Lauren Opremcak Bakaletz and David E Cohn. These collaborations have further enriched his research and development efforts, leading to significant advancements in his field.
Conclusion
Pravin T Kaumaya's innovative work in immunology and his contributions to the development of therapeutic compositions highlight his role as a leading inventor. His patents and collaborations continue to pave the way for advancements in cancer treatment and immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
